Cell Signaling Technology

0.5 M EDTA, pH 8.0

#7011 · $42

100
Citing papers
15.2k
Combined citations
Supplier page Find this product

Research areas

Glioma Diagnosis and Treatment25Cancer Cells and Metastasis22Epigenetics and DNA Methylation14MicroRNA in disease regulation12Neurogenesis and neuroplasticity mechanisms8RNA modifications and cancer7Microtubule and mitosis dynamics6Cancer, Hypoxia, and Metabolism5

Papers citing this product

1
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
BMC Medicine·2008·948 cit.·DOI
2
CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
Blood·2010·717 cit.·DOI
3
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Neuro-Oncology·2010·708 cit.·DOI
4
NOTCH Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts  
Stem Cells·2009·643 cit.·DOI
5
Gain-of-function mutations in <i>interleukin-7 receptor-α</i> ( <i>IL7R</i> ) in childhood acute lymphoblastic leukemias
The Journal of Experimental Medicine·2011·346 cit.·DOI
6
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
Blood·2009·345 cit.·DOI
7
BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal
Journal of Neuroscience·2009·342 cit.·DOI
8
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
Laboratory Investigation·2008·331 cit.·DOI
9
Intratumoral Hypoxic Gradient Drives Stem Cells Distribution and MGMT Expression in Glioblastoma
Stem Cells·2010·317 cit.·DOI
10
HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway
Cell Death and Differentiation·2011·308 cit.·DOI
0.5 M EDTA, pH 8.0 — Evidence — PubIndex